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INTRODUCTION 
One of the most commonly experienced symptoms in dentistry and one 
that is of major concern to the dentist is pain. Since pain is mani­
fested when an enviromental change occurs causing injury to responsive 
tissues, it is often spoken of as a protective mechanism. 
Pain has been described by a variety of terms: sharp, burning, 
aching, cramping, dull and throbbing! (Manheim, 1969). Therefore, 
it is a difficult term to define. Manheim (1969) describes pain as an 
unpleasant sensation created by a noxious stimulus that is mediated 
along specific nerve pathways into the central nervous system, where 
it is interpreted as pain. 
Local anesthetics are drugs that will temporarily interfere with 
conduction when absorbed into the nerve. A blockage of the afferent 
transmission produces analgesia, while interruption results in motor 
paralysis. 
Local anesthetic compounds are the most widely used drugs in 
dentistry and all are synthetic compounds with the exception of cocaine 
which no longer is used because of its unusual high toxicity. 
Structural changes in the molecules of these drugs alter the toxicity, 
potency, diffusibility, profoundness, and duration of anesthetic activity 
of these compounds. Frequently, as the length of the anesthetic 
molecule increases, so does its anesthetic activity. Also, structural 
changes in the molecule may increase toxicity or irritancy without 
increasing potency. In most cases toxicity tends to rise as potency 
increases. 
Manheim (1969) has suggested that ideal local anesthetics should 
possess the following properties: 
(1) Its action must be reversible. 
(2) It should have a low degree of systemic toxicity. 
(3) It should have a rapid onset and be of sufficient duration 
to be advantageous. 
(4) It should have a potency sufficient to give complete 
anesthesia without using harmful concentrated solutions. 
(5) It should have sufficient penetrating properties to be 
effective as a topical anesthetic. 
(6) It should be relatively free from production of allergic 
reactions. 
(7) It should be stable in solution and readily metabolized 
by the body. 
(8) It should be either sterile or capable of being sterilized 
by heat without deterioration. 
(9) It must be nonirritating to the tissues and produce no 
secondary local reaction. 
No local anesthetic in use today fulfills to perfection all of these 
requirements. 
Since local anesthetics are the most commonly used drugs in 
dentistry for routine procedures when anesthesia is desired, it is of 
particular interest to study the morphologic changes in the muscles 
that are situated in close proximity to major sensory nerve fibers 
to the teeth. It is also of interest to question that local 
anesthetics are nonirritating to the tissues; in fact, they do 
produce a definite and precise lesion. 
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Another point of interest is to use and apply local anesthetics 
to produce a definite lesion clinically to aid in the treatment of a 
common dental syndrome, the myofacial pain dysfunction syndrome 
formerly known as Costens Syndrome. 
3 
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REVIEW OF THE LITERATURE 
The major muscles of mastication are the masseter, medial and 
lateral pterygoids, and the temporalis and they are involved in most 
movements of the mandible. These muscles are situated anatomically 
near the sensory nerve fibers to the teeth. As a consequence, portions 
of some of the muscles of mastication may be affected due to the in­
filtration of anesthetic solutions following a mandibular block, and 
in infiltrating for superior alveolar nerves, long buccal and 
palatine nerves. In addition, intramuscular injection inadvertently 
may occur. 
Many investigators have studied the effects of chemical injury 
due to local anesthetics used commonly in dentistry. (Benoit, 1971; 
Margolis, 1953; Tait, 1958; Brun, 1959; Burke, 1972) A previous 
study indicated that certain local anesthetics used in dental offices 
would produce degenerative lesions in skeletal muscle followed by 
regeneration of injured muscle fibers (Benoit, 1971). 
Burke (1972) described degenerative changes in striated muscle 
of the rat tongue following injection of 2% Lidocaine HCl without 
vasoconstrictor. Lidocaine caused degeneration in muscle fibers by 
12 hours, and degeneration was severe to the extent that all myofibrils 
in some fibers disappeared leaving behind empty sacrolemma sheaths. 
Benoit (1971) described the effects of some local anesthetics on the 
gracilus muscle of the rat. Following a subcutaneous injection of 
2% Lidocaine HCl without vasoconstrictor, the muscle fibers showed 
hyalinization and phagocytosis of the necrotic debris. Regeneration 
was well established by three days and was complete by two weeks 
(Benoit, 1971). Mannheimer, Pizzolato and Adriani (1955) also 
described the effects of 2% Lidocaine on rat skeletal muscle, and 
reported similar results. Similar investigations have been done with 
l to 4% Procaine and Carbocaine (Margolis, 1953; Tait, 1958; 
Mannheime� 1954). Brun (1959) showed Carbocaine and Xylocaine 
regularly produced inflamation and necrosis in rat skeletal muscle. 
Procaine produced no irritation nor lesion. Burke (1972) showed that 
Tetracaine and Lidocaine produce degenerative lesions in the rat 
tongue followed by repair. Procaine produced no lesions other than 
those noted along the path of injection. 
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The use of Xylocaine in dentistry has been described as producing 
reactions. Weidling (1948) and Lunqvist and Lofgren et al (1948) showed 
that "These reactions were due to metal ions, especially copper, 
released by acid injection solutions. In these solutions a low pH is 
necessary to stabilize the adrenaline. The metal ion sometimes leads 
to hemorrhagic edema, associated with an inflamatory reaction." 
Gordh (1948) found that intra and subcutaneous injections of 1% 
Xylocaine without a vasoconstrictor produced no demonstrable reaction 
in man. 
Bjorlin (1954) found that Xylocaine without adrenaline had a 
much stronger local irritative effect in skeletal muscle of the rat 
than did Procaine in equal concentrations. During the first days 
after the injection of Procaine, gross hemorrhages and microscopic 
degenerative changes were seen in the connective tissue, and vascular 
damage with thrombosis and hemorrhages as well as inflamation were 
noted. These alterations subsided on the third day and then disappeared. 
Xylocaine produced similar, but more pronounced alterations which 
persisted for one week. Brum (1958) showed that subcutaneous injections 
of Xylocaine and Carbocaine in the rat resulted in relatively wide 
spread alterations. The lesions were localized and consisted of 
infiltrations of histiocytes and fibroblasts between muscle fibers, 
which also showed hyalinization and disintergration, as well as a 
decrease in fiber diameter. 
Opinions thus differ on the effects of local anesthetics on 
skeletal muscle. Gross inspection of the reaction of the tissue to 
an anesthetic must surely be of some value. Discrepancies have been 
found between results of microscopic and macroscopic studies. Such 
discrepancies have indicated that variations in reaction to local 
anesthetics range from the production of no lesion or irritancy, 
to degenerative lesions and ultimately to necrotic lesions. 
Local anesthetics have been shown to affect muscle tissue 
at different degrees of reaction. Such observations suggest a way of 
using certain local anesthetic agents to the advantage of the dental 
clinician. 
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HISTORY OF LOCAL ANESTHETICS 
The first local anesthetic agent to be discovered was Cocaine, 
which had been used for centuries by the natives of the Peruvian 
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Andes in the form of Cocoa leaves. Nieman in 1860 first isolated the 
substance and noted it made his tongue numb . Von Antrep in 1879 studied 
its properties and reactions and reported that subcutaneous injection 
produced insensitivity to a pinprick . 
Cocaine was brought into clinical use as a local anesthetic agent 
in ophthanologic procedures after the studies of Koller and Freud in 
1884 . It was rapidly brought into use in dentistry later in 1884 by 
Hall. 
Also in 1884, Halstead administered the first inferior alveolar 
nerve block with Cocaine . By 1892, Einhorn had begun the search for 
synthetic substitutes, this led to his synthesis of Procaine in 1905. 
PURPOSE 
The purpose of this experiment is to clarify and describe the 
morphologic effects of some local anesthetics on the muscles of 
mastication using light microscopy. The information derived from 
8 
this study will be used to describe the course of the developing 
lesion in muscle caused by local anesthetics and subsequent regenera­
tion of damaged components of the muscle fibers. It will also clarify 
that local anesthetics seemingly produce a degenerative lesion and not 
a necrotic one. It may also help to explain the observation that 
relief is often obtained following injection of local anesthetic 
in muscles affected by spasm and trismus so often encountered by the 
dental practitioner when he diagnoses the presence of the myofacial 
pain dysfunction syndrome. 
LOCAL ANESTHETICS USED IN DENTISTRY 
Local anesthetics used in dentistry can be divided into two 
groups: the ester compounds and the amide type compounds. 
The ester group was at one time the most commonly used. It is 
composed of l) an aromatic, lipophilic group 2) and intermediate chain 
containing an ester linkage 3) a hydrophilic secondary or tertiary 
amino group which forms water soluble salts combined with acid. 
The chemical pattern of the ester type compounds is as follows: 
R2 H 0 H H C2H5 
II 
R � - ;>cooR -- N or N-�-// C-0-C-C-N 
Rl H H H C2H5 Procaine 
T�e amid2 group, which is presently the most popular, is composed 
of 1) an aromatic, lipophilic group 2) an intermediate chain contain­
ing an amide linkage 3) a hydrophilic or tertiary amino group which 
forms water soluble salts when combined with acids. 
The following structure represents the chemical pattern of the 
amide compounds. 
R3 CH3 C2H5 
R 4--v -NHCO-R2--N or 4 .,) -NH-CO-CH2-N 
R4 
Lidocaine 
CH3 C2H5 
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PROPERTIES OF AN IDEAL LOCAL ANESTHETIC 
Local anesthetic compounds that are synthetic are weakly basic 
in nature and as such are poorly soluble in water. They are, however, 
combined with hydrochloric acid to form salts that are soluble in water 
and acid in reaction. Their chemical characteristics are so balanced 
that they have both lipophilic and hydrophobic properties. If the 
hydrophilic group predominates, the free base is not readily precipitated 
on injection into the tissues, and the ability to diffuse into the 
lipid-rich nerves is diminished. If the molecule is too lipophilic, it 
is of little clinical value as an injectable anesthetic, since it is 
insoluble in water and unable to diffuse through the interstitial 
tissues (Manheim, 1969). 
Toxicity, as well as potency, varies with the chemical structure 
of local anesthetics. The chemical structure of the ideal local 
anesthetic would make possible the combination of high potency and 
low toxicity. In many instances changes of the chemical formula may 
increase only slightly potency but increase markedly toxicity of the 
new compound. Therefore toxicity, potency and local irritancy, 
although related, are of extreme importance. The degree of toxicity 
does not always coincide with potency (Manheim, 1969). However, as 
a general rule, as potency increases, toxicity is likewise increased. 
Injectable local anesthetics, while chemically different in many 
respects, possess the following common properties (Manheim, 1969): 
( 1 ) They are all synthetic compounds. 
(2) They al 1 contain amino groups. 
(3) They all form salts with strong acids. 
(4) Their salts are water soluble. 
(5) Alkali will hydrolize the salt to free the alkaloidal base. 
(6) The alkaloidal base is soluble in lipids. 
(7) The anesthetic salts are acid in reaction and relatively 
stable. 
(8) They are all either hydrolyzed by plasma esterases or 
detoxified in the liver. 
(9) The action of all drugs are reversible. 
(10) They are all compatible with epiniphrine or other vaso­
constrictors. 
(11) They are incompatible with metal salts of mercury, silver 
etc. 
(12) They are all capable of producing toxic systemic effects 
when sufficiently high plasma concentration is reached. 
(13) They all affect nerve conduction in a similar manner. 
(14) They all have little or no irritating effects on tissues in 
anesthetic concentration. 
It is the last property which is of question at this time. 
Local anesthetics can be grouped according to their chemical 
structures. This is particularly important from the point of view of 
metabolism as well as from that of possible allergic reaction. 
The chemical groups of the injectable anesthetics used are: 
I. Para-amino benzoic acid esters 
A. Procaine (Novocaine) 
II. Anilide (nonester type) 
A. Lidocaine (Xylocaine) 
B. Mepivacaine (Carbocaine) 
C. Prilocaine (Citanest) 
11 
As a general rule the potency of a local anesthetic depends upon 
its chemical structure, whereas the duration can be altered by the 
addition of a vasoconstrictor drug. 
Local anesthetic agents differ considerably from most other 
classes of drugs. For example, local anesthetic agents are applied 
directly to the region of the body in which they exert their desired 
pharmocologic action whereas most other drugs are administered 
parenterally or orally and then transported by the circulatory system 
to their target organ, which is located at some distance from the site 
of administration. 
Although local anesthesia has been an accepted clinical procedure 
for many years and the use of local anesthetic agents has been wide­
spread in the general population, basic pharmocologic knowledge 
(Covino, 1972) and the study of adverse affect on muscle has been 
relatively sparse. 
The purpose of this report is to describe the developing lesion 
in the muscles of mastication. No attempt will be made to describe 
or discuss the mechanism of action of local anesthetic agents on 
peripheral nerves, nor will 
conduction be considered. 
the physiology on nerve excitation and 
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CHEMISTRY AND PHARMACOLOGY 
Procaine 1 - (Winthrop Labs): 
Procaine (diethylaminoethyl ester of para-aminobenzoic acid) was 
synthesized by Einhorn in 1 905, and for over fifty yea rs it was con­
sidered the standard of comparison for the local anesthetics (Monheim, 
1 971 ). The introduction and wide acceptance of the nonester type 
local a�esthe�ics have reduced the importance of procaine. However, 
throughout the period of its extensive use it has had an enviable 
safety record (Monheim, 1 969). 
H 0 H H C2H5 
� � 
II 
Chemistrt: N C-C-C-N 
H H H C2H5 
Procaine (Novocaine) is a white crystalline powder having a 
melting point of about 60° C. The drug itself is only slightly 
soluble in water and has an alkaline reaction. However, it is most 
commonly used as the hydrochloric salt, which is freely soluble in 
water and is acidic in reaction, having a pH of approximately 4.5 and 
a melting point of 1 54°c. Solutions of procaine hydrochloride are 
decomposed rapidly by alkali but withstand boiling and autoclaving. 
The drug is compatable with epinephrine, phenylephrine, corbasil and 
1 eva rte reno 1 . 
Pharmacology: Procaine is a weak anesthetic agent possessing a 
low degree of toxicity. It produces analgesia under practically all 
circumstances. 
1Procaine, �Jinthrop Laboratories, N. Y. , N. Y., 1 971. 
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Procaine is readily absorbed following injection into the tissues 
and is hydrolyzed to para-aminobenzoic acid and diethylaminoethanol. 
This is be 1 i eved to be accomp 1 i shed by t,1e enzyme pseudocho 1 i nes tesase, 
which is present in the plasma and the liver. The end products, 
particularly para-aminobenzoic acid, are excreted by the kidney. 
Due to its rapid hydrolysis, Procaine has a low degree of systemic 
toxicity. It does possess vasodilatating properties that cause it to 
be more readily absorbed into the syste�ic circulation. This more rapid 
absorption and subsequently increased toxicity can be markedly controlled 
by the addition of a vasoconstrictor to procaine solutions. 
Procaine is used in dentistry in 2% solutions. This percentage 
strength is nonirritating (according to the manufacturer) to tissues 
and has sufficient anesthetic potency to ensure adequate analgesia. 
Procaine should not be used in concentrations exceeding 2%, as the 
vasodilating action shortens the anesthetic time and markedly increases 
the toxicity. 
The onset of analgesia with procaine depends to a degree upon the 
concentration and the method employed. Procaine has no effect upon the 
cardiovascular system other than vasodilatation of the microcirculation 
in the area of injection since it is, depending upon the concentration 
used, a mild to potent vasodilator (Monheim, 1969; Novocain, 1966). 
Lidocaine 1 - (Astra Pharmaceutical): 
Chemistry: 
CH3 H c2H5 
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The structural formula of Lidocaine (diethylamino acet-2, 6-xylide; 
Xylocaine), represents an important chemical departure from the procaine 
type {para-aminobenzoic acid ester) local anesthetic, because Lidocaine 
is the first non-ester type local anesthetic compound to be used in 
dentistry. It is a white crystalline powder with a melting point of 
69°c and is used as the hydrochloride salt. The drug is compatable with 
all vasoconstrictors and withstands boiling and autoclaving. Lidocaine 
base is only slightly water soluble, but the hydrochloride salt is 
readily soluble in water (Lidocaine, Astra-Pharmaceutical 1 966). 
Pharmacology: Lidocaine diffuses readily through interstitial 
tissues and into the lipid rich nerve, giving a rapid onset of 
anesthesia (Manheim, 1969). Lidocaine has a pKa of 7.85 and therefore 
creates a favorable rate of ionization and the production of a 
conduction block (Astra-Pharmaceutical 1966). 
Experimental investigations on man and animals has established 
the potency of lidocaine to be 2-3 times that of procaine. The type 
of anesthesia induced by this agent has been found to be rapid, 
extensive, profound, highly predictable and longer lasting than procaine 
(Wiedling, 1952; Goldberg 1 947). In general, it leaves the site of 
injection at a slower rate than procaine (Sung, 1954). 
llidocaine Hydrochloride, Astra Pharmaceutical Products Inc., 
Worchester, Mass., 1966. 
Carbocaine 1 - (Winthrop Laboratories) 
Chemistry: 0 H CH3 
II - C--N-�-.,> 
CH3 
Carbocaine (d, 1-N methyl - pipecolic acid - 2, 6 dimethylanilide; 
Mepivacine) is a white crystalline, odorless powder that is soluble 
in water, and very resistant to both acid and alkaline hydrolysis. It 
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is a nonester anilide compound with a melting point of 261°c and a 
molecular weight of 285. 5. The drug is compatible with all vasoconstric­
tors and withstands boiling and autoclaving (Winthrop Labs, 1971). 
Pharmacology: Carbocaine is very similar to lidocaine in its 
action within the body. It produces anesthesia of moderately long 
rate by stablizing the neuronal membrane and prevents the initiation 
and transmission of nerve impulses. "Carbocaine does not ordinarily 
produce irritation or tissue damage" (Winthrop Labs, 1971). 
Citanest2- (Astra Pharmaceuticals) 
CH3 
Chemistry: (, -.1) - NH-CO-CH-NH-CH2-CH2CH3 
CH3 
Citanest (a-n-propylamino-2 methyl-propronanilde; Prilocaine) 
is a stable amide whose hydrochloride salt is freely soluble in water. 
It has a molecular weight of 256. 8 and a melting point of 167° to 1680C. 
Pharmacology: Citanest is a short acting local anesthetic whose 
potency and safety is comparable with lidocaine (Astra Pharmaceutical, 1965). 
It is said to have a lesser degree of toxicity to the central nervous 
'1carbocaine Hydrochloride, Winthrop Laboratories, N. Y. , N. Y. , 1971. 
2
citanest Hydrochloride, Astra Pharmaceutical, Worchester, Mass., 1965. 
system than lidocaine and is more rapidly metabolized. The drug is 
absorbed from the injection site less rapidly than is lidocaine. 
Metabolic studies indicate that Citanest is broken down in the 
liver much more rapidly than lidocaine. Citanest is a derivative of 
toluidine and therefore one of the metabolites of citanest appears to 
17 
be 0-toluidine, a substance which has been found to produce methemoglobin; 
and it is consequently contraindicated in those rare patients with 
congenital or idiopathic methemoglobinemias ( Astra Pharmaceutical, 1965). 
PROCEDURE 
90 Wistar white female rats obtained from Flow Laboratories, 
Dublin, Virginia, weighing approximately 150 grams each, were divided 
into five groups, 18 animals to a group. Each group was sub-divided 
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into five subgroups consisting of 3 animals in each subgroup. The animals 
were anesthetized with Metafane (Methoxyflurane) by placing each animal 
in a closed jar with a few drops of anesthetic. Once anesthesia was 
obtained, the animal was placed on a head restraint and its mouth 
propped open. Both masseter muscles, anterior deep divisions were 
injected with 0.25 ml alloquots of the agents intraorally, using a 22 
guage 1 inch needle. The following local anesthetic agents were used: 
(1) 2% Lidocaine HCl (Astra Pharmaceutical); (2) 2% Procaine HCl 
(Winthrop Laboratories); (3) 3% Carbocaine HCl (Winthrop Laboratories); 
(4) 4% Citanest HCl (Astra Pharmaceutical); (5) Isotonic Saline. All 
were administered without vasoconstrictor. The injected animals were 
then sacrifice�, at days 1 , 2, 3, 4, 7, and 15. The heads were removed 
and fixed for 24 hours in 10% neutral buffered formalin. The anterior 
deep division of both masseter muscles were than dissected, washed and 
processed for sectioning at 5-7 micra, and stained with hematoxylin and 
eosin. 
Discussion: 
Metafane R (Methoxyflurane)1 is a halogenated ethyl methyl ether 
with the clinical name, 2, 2-dichloro-1, 1-difluroethyl methyl ether. 
It contains 0.01% Butylated hydroxytoluene as the antioxidant. It is a 
lMetafane (Methoxyflurane), Pitman-More Inc., Fort Washington, PA, 
1 969. 
non-explosive type of inhalation anesthetic and exhibits low toxicity. 
It maintains anesthesia with ease and possesses marked muscle relaxing 
properties. It has a wide margin of safety between surgical levels 
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and toxic levels. Recovery is smooth and of short duration. It is 
compatible with commonly used preanesthetic and other anesthetic agents. 
Clinical-pathological tests with methoxyflurane have shown that 
minimal hepatic damage occurs only on gross overdosing. The depth of 
anesthesia 1�as based on clinical judgement and by the degree of 
muscle relaxation and the rate and character of respiration. Loss 
of muscular tension of the limbs, operative site, and jaws were reliable 
signs of adequate surgical anesthesia (Pitman-Moore Inc., 1969). 
MATERIALS AND METHOD 
On the day of sacrifice, the animals were placed in a glass jar 
with ether until death. The heads were skinned, exposing the injected 
muscle, removed and fixed in 10% neutral buffered formalin for 24 hours. 
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A biopsy of the anterior deep division of the masseter muscle, bilaterally 
was obtained. The specimens were identified and prepared for proper 
fixation and preparation for paraffin sections as described by Lilly (1965). 
Preparation of tissues for Light Microscopy 
Fixation 24 to 48 hours 
H20 Washing 1 hour 
70% ETOH 12 hours 
80% ETOH hour 
95% ETOH hour 
100% ETOH hour 
100% ETOH hour 
100% ETOH + Chloroform hour 
Chloroform hour 
Chloroform + Paraffin hour 
Paraffin hour 
Paraffin hour 
Embedding in paraplast block 
Sections of the biopsies were cut at 6 to 10 micra and stained with 
hematoxylin and eosin, followed by dehydration and mounting. 
Hematoxylin and Eosin Staining of Tissue Sections : 
1. Deparaffinization 
Xylene 
Xylene 
2 minutes 
2 minutes 
2. H2 0 
100% ETOH 
95% ETOH 
80% ETOH 
3. Harris' hematoxylin 
4. H20 
5. Differentiation and Alcohol 
0. 50% 
6. Rinsing in tap water 
7. Bluing with Lithium 
Carbonate 
8. Eos in 
9. Dehydration 
95% ETOH 
95% ETOH 
100% ETOH 
100% ETOH 
10. Clearing 
Xylene 
Xylene 
Xylene 
1 1. Mount with Permount 
12. Dry 
6 dips 
6 dips 
6 dips 
rinsing 
15 minutes 
rinsing 
2 dips 
minute 
3 dips 
15 seconds 
2 dips 
2 dips 
2 minutes 
2 minutes 
3 minutes 
3 mi nut es 
3 minutes 
Histologic changes in muscle were than observed. Bethlems 
interpretation of muscle biopsy was chosen as an aid in determining 
histologic changes in muscle: 
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INTERPRETATION OF A MUSCLE BIOPSY 
l. Changes in fiber diameter 
2. Changes in the structure of muscle fibers 
a. Fl occu la r changes 
b. Hyaline Degeneration 
c. Basophillia 
d. Vacuoles 
Ringed fibers and sarcoplasmic 
Changes in sarcoplasmic nuclei 
masses. 3. 
4. 
5. 
6. 
7. 
8. 
Changes in the muscle spindle fibers 
Changes in the intramuscular nerve branches. 
Changes in the blood vessels. 
Changes in the interstitial tissues. 
9. Cellular infiltration. 
10. Pattern of the lesion. 
Discussion: 
Muscle tissue has a relatively limited range of histologic changes 
in reaction to disease (Bethlem, 1970). It is therefore necessary to 
elaborate on what is to be observed in an interpretation of a muscle 
biopsy. 
Changes in muscle fiber diameter can only be judged with any 
reliability in transerse sections. The diameter of the fibers are 
dependent on the fixation method, sex and age, the muscle examined 
and the nutritional state of the subject. 
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Structural changes consist of floccular collections of eosinophilic 
material in conjunction with phagocytosis. These changes are often referred 
to as necrotic changes. 
Hyaline degeneration is the term applied to a swollen muscle 
fiber whose cross striations are no longer recognizable. These fibers 
often contain a homogenous eosinophilic material. Waxy degeneration, 
cloudy aspect (Greenfield, Shy, Alvord and Berg, 1957), degenerescence 
vitreuse (Durante 1902) and Wachsartige degeneration (Zenker 1864) are 
other terms often encountered to describe this change. 
Basophilic fibers represent an increase of ribonucleic acid 
indicative of repair. 
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RESULTS 
Procaine, Lidocaine, Carbocaine and Citanest exhibited the same 
morphologic changes; therefore all four will be discussed together. 
Figures 1 through 4, pages 39-42 are self-explanatory. 
Day 1 (refer to Figure 5 and 6) 
The first noticeable change in the region of deposition of local 
anesthetic was the massive infiltration of inflamatory cells (Figure 5, 
Lidocaine day 1). The interstial tissues show marked edema with 
numerous polymorphonuclear leukocytes and macrophages. Myofibrils 
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became disrupted with vacuoles, leaving some empty sarcolemma tubes. 
Cross striations disappeared. Flocular changes occurred with fibers 
showing marked eosinophillia and phagocytosis of the myofibrillar debris. 
Hyalin degeneration was evident with fiber diameter increasing in size. 
The once peripherally placed elongated sarcolemma nuclei now became 
very prominent with migration into the center of the fiber. The 
swollen appearing vesicular nuclei continued to exhibit a marked increase 
in hyperchromicity. The nuclei which were present with the myofibrils 
and in the endomysium were of polymorphonuclear leukocytes and macro­
phages. No evidence of mitosis was observed, nor was there evidence 
to suggest how an increase in intrafiber nuclei came about. Many muscle 
fibers lost their myofibrils by phagocytosis, but still retained an intact 
sarcolemma, leaving an empty sarcolemmal tube with a small peripheral 
sheath of sarcoplasm and muscle fiber nuclei. 
The cross section photomicrograph (Figure 6) reveals marked edema 
in the endomysium. The individual fibers show varying degrees of 
degeneration. Point A (Figure 6) represents the peripheral arrangement 
of nuclei showing marked hyperchromicity and migration into the center 
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of the fiber. Vacuolization is also present with phagocytosis of the 
myofibrillar debris. Point B (Figure 6) represents another stage in 
degeneration in which the peripherally boardered nuclei have migrated 
centrally, phagocytosing the myofibrillar debris. The interstitial 
cellular infiltrate can be seen clearly in Figure 6 as polymorphonuclear 
leukocytes and macrophages. 
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Day 2 - (Refer to Figures 7 and 8) 
The evidence of injury at 48 hours post injection is quite remarkable. 
As revealed in figure 7, vacuolization became more evident. A marked 
increase in celluarity is quite apparent within both the individual 
damaged muscle fibers and interstitium. Highly basophilic multinucleated 
tubes predominate which represent empty muscle fibers with an intact 
sacrolemma. Nuclei appear disorderly in appearance in some fibers and 
are more organized in others. Nuclear movement seems to be directed 
toward the center of the fiber forming a continuous line of nuclei. 
Fiber diameter decreased (Figure 8) but a peripheral rim of 
basophilic cytoplasm is apparent. Large vesicular cells with pale 
nuclei and prominent nucleoli with basophilic cytoplasm appear on the 
periphery of the damaged fibers. These cells resemble myoblasts and 
will form new skeletal muscle fibers. 
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Tissues which were autopsied at 72 hours post injection revealed 
minor changes and closely resembles the 48 hour picture. The highly 
basophilic multinucleated tubes overwhelmingly predominated. Long 
strains of nuclei were beginning to organize within the center of the 
damaged muscle fibers. Fiber diameter still remained diminished in size. 
Polymophonuclear cells became less numerous being replaced by large 
oval cells with basophilic cytoplasm and prominent multiple nucleoli. 
These cells typically resembled myoblasts but their origin remains 
unknown. 
28 
Day 4 - (Refer to Figures 9 and 10) 
By day 4, myofibrillar regeneration has progressed at a rapid 
rate. The marked basophilic multinucleated tubes are quite evident 
(Figures 9 and 10). Large vesicular nuclei with very large prominent 
nucleoli became very well organized. The nuclei seemed to be attracted 
to each other and were lined up side by side to form a continuous chain. 
The sarcoplasm was intensly basophilic, indicative of ribonucleic 
acid synthesis. Interstial tissues still showed evidence of edema with 
a highly disorganized cellular infiltrate of large basophilic cells with 
ovoid nuclei. These cells also appear to be disorganized inmature 
myoblasts and to have produced myofibrillar substances which coalesced, 
forming new skeletal muscle fibers. 
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Day 7 - (Refer to Figure 11) 
On day 7, the muscle fibers were losing their basophilic appearance 
and showed increases in eosinophillia. Large centrally placed hyper­
chromatic nuclei still were evident. The cells of the interstitium 
were progressively becoming organized and synthesizing a homogeneous 
basophilic substance. These cells apparently were myoblasts, whose origin 
is unknown. They produced a myofibrillar cytoplasm which replaced 
the injured fibers as was evident in the cross section photograph of 
figure 11. Nuclear organization was quite remarkable with long 
continuous strains of centrally placed nuclei within the regenerating 
fibers. 
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Day 15 - (Refer to Figures 12 and 13) 
By day 15 regeneration was almost complete. Figure 12 reveals 
intact fibers with cross striations. These fibers exhibited the 
multinucleated centrally placed vesicular nuclei as mentioned previously. 
Point A (Figure 13) reveals an interesting phenomena in which nuclear 
fragmentation seemed to be taking place, leaving behind a normal 
appearing muscle fiber with peripherally placed elongated nuclei. 
Sarcoplasmic basophillia indicative of protein synthesis and repair, 
has been replaced by normal eosinophilic cytoplasm. Fiber diameter 
increased in size and cross striations have reappeared. 
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Saline Control (Firgure 14) 
In control animals, muscle fibers in the region of infiltration 
exhibited only mild degeneration in the localized region of injection. 
Degeneration of the muscle fibers was not truly evident until day 3. 
Morphologically, the cells present were basically polymorphonuclear 
leukocytes and macrophages. The cellular pattern typically represented an 
acute inflamatory response in the early stages. By day 4, muscle fibers 
exhibited a decrease in cross striations and the sarcoplasm showed 
marked basophillia with large centrally placed vesicular nuclei. The 
nuclei exhibited hyperchromatism with prominent nucleoli. 
The region of degeneration was so small and localized that it is the 
author's point of view that this degenerative pattern was due to the 
injection of the saline solution. By day 15, repair was complete to 
the extent that no evidence of scar tissue was present and cross striations 
appeared as in normal striated muscle. Pycnotic nuclei were peripherally 
located and the sarcoplasm exhibited its normal color. 
Discussion 
The sequence of morphologic changes in the muscles of mastication 
following a single injection of either Lidocaine, Carbocaine, Citanest 
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or Procaine clearly indicates a rapid reversable destruction of striated 
muscle fibers followed quickly by phagocytosis and regeneration. Benoit 
(1970) observed the irreversible destruction in the gracilis posterius 
muscle following a single injection of Bupivacaine, long acting local 
anesthetic, followed by regeneration by 30 days. The fact that regenera­
tion does occur implies that necrosis does not take place. In the region 
where no local anesthetic agent is deposited, the degenerative tissues are 
removed rapidly by macrophage activity fol lowed by a regrm�th of new 
cellular materi31 which is derived from either the stump of old unaffected 
fibers or from new myoblasts. The origin of the myoblasts presently is 
unknovm. 
As the affected fibers degenerate, an orderly sequence occurs. A 
floccular change, characterized by collections of eosisophillic material 
and phagocytosis, is the first of a series of changes. Hyaline degeneration 
is second, characterized by the appearance of swollen fibers with a loss 
of cross striations and a homogeneous eosinophilic sarcoplasm. 
Basophillia follows shortly, representing a repair process, replacing 
the myofibrillar sarcoplasm. 
Nuclear changes are very drastic. The normally elongated nuclei 
of the muscle fibers are called sarcolemmal nuclei because they are 
situated just beneath the sarcolemma. According to Greenfield, Shy, 
Alord and Berg (1957), an average of four to eight nuclei per fiber is 
normal in cross sections. Fiber degeneration followed by regeneration 
shows a marked increase of nuclei with the formation of nuclear chains 
seen only in longitudinal sections. The interval between the nuclei 
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in a chain can be so slight that the nuclei cannot be individually 
identified. These nuclei are large and vesicular in shape and exist for 
only a short period of time. Subsequently they disperse , leaving behind 
a skeletal muscle fiber with eccentrically peripherally placed elongated 
sarcolemma nuclei. The early invasion of polymophonuclear leukocytes and 
macrophages clearly indicates an acute inflamatory response or a polymyositis. 
The origin of the myoblasts remains a mystery, although transformation of the 
macrophage into a myoblast cannot be ruled out until proven otherwise. 
Mitotic activity was not observed, although the possibility always exists 
that a specific time in the degeneration of an intact muscle fiber, nuclei 
of adjacent unaffected myofibrils migrate to the affected fibers and revert 
to blastic forms. 
The Vascular response of the tissues was not of any remarkable 
significance. No granulomatous tissue appeared. 
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Clinical Significance 
There have been a number of reported cases of patients who complain 
of discomfort and pain in the preauricular region radiating up to the 
temporal region. In some of these patients, opening of the mouth causes 
severe discomfort. This discomfort can become so unbearable that the 
patient refuses to eat, leading to weight los s and dehydration. There 
has also been reported cases in which patients have committed suicide 
because of the unbearable pain as sociated with this myofacial pain 
dysfunction syndrome. 
Most dental clinicians feel that the majority of such patients 
are experiencing pain due to malocclusion of the teeth. Other clinicians 
feel that there are other reasons for this syndrome. The psychological 
and stress factor cannot be ruled out as a contributing factor, nor can 
faults developing in the temporomandibular joint be ignored. As one 
can clearly see, no one cause can be the specific etiologic factor in 
the myofacial pain dysfunction syndrome. Joint pathology, muscular 
incoordination and trismus, malocclusion and stress must be considered 
to. 
It is the author ' s  point of view that patients complaining of facial 
pain when all pathology is ruled out, are experiencing a number of 
problems. Stress associated with some family or personal problem causes 
muscle tensions and spasms leading to incoordination of the muscles of 
mastication. The stress causes bruxing or clenching of the teeth 
subconsciously. This leads to pain and fatigue. To relieve the patient 
of pain, a reveris ble procedure must be used. The injection of local 
anesthetics without vasoconstrictors into the origin and insertion of the 
affected muscle causes the immediate relief of pain. Muscle fibers 
degenerate and regenerate by 30 days without evidence of scarring. 
The patient is also placed on tranquilizers and followed for a period 
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of two weeks . While the patient is free of discomfort, the psychological 
problem hopefully will have decreased and the trismus and spasms will 
have subsided. 
This method of treatment is a more conservative and reversible one 
compared to complete occlusal adjustments and surgery. 
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Summary : 
l. The local anesthetics Lidocaine , Carbocaine, Citanest and 
Procaine were administered intramuscularly into the anterior boarder 
of the masseter muscle bilateraly of 90 Wister rats. 
2. Degeneration of the muscle fibers progressed followed by 
regeneration. 
3. Necrosis of the muscle fibers did not occur. 
4. The lesions produced by all the local anesthetics were 
essentially the same for all the local anesthetics tested. 
5. The lesion produced was reversible. 
6. The clinical significance of using local anesthetics in the 
treatment of myofacial pain dysfunction syndrome must be considered 
as an adjunct to therapy because of its reversibility and conservatism. 
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Figure 1. Injection of local anesthetic into the anterior deep division 
of the masseter muscle. 
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Figure 2. Dissected head revealing the needle  pathway and masseter 
muscl e. 
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Figure 3. Muscle biopsy of a normal masseter muscle. 
Figure 4. Muscle biopsy of an injected masseter muscle. Note change in 
appearance of tissue in the upper left region of the sampl e 
as compared to Figure 3. 
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Figure 5. 24 hours post i njection: lOOX-LS: Interstial tissues show 
marked edema w ith numerous polymorphonuclear leukocytes and 
macrophages. Myofibrils are disrupted and cross str i ati ons 
have d isappeared. 
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Figure 6. (lOOX-XS) 24 hours post injection revealing marked cellular 
infiltrate and varying degrees of degeneration. 
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Figure 7. 48 hours post injection (lOOXLS) Marked vacuolization of fibers 
leaving multinucleated tubes with an intact sarcolemma. 
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Figure 8. 48 hours post injection (lOOXLS) revealing basophilic peripherally 
placed sacroplasm and a decrease in fiber diameter. Note 
cellular infiltrate both within the interstitium and fibers. 
Figure 9. 
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(lOOXLS) Marked basophil ic multinucleated tubes with l arge 
vesicular nuclei and prominent nucleoli. Note that the 
nuclei are centrally placed and are lining up side by side 
to form a continuous chain. 4 days post injection. 
Figure 10. Day 4 (lOOXLS) Note relatively unaffected fibers on right 
and affected fibers on left. 
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Figure 11. 7 days post injection (20X-XS) large centrally placed nuclei 
in the damaged region in the lower half represent the repair 
process as compared to the peripherally pl aced nuclei of the 
uninjured fibers in the upper half of the photograph. 
Figure 12. 1 5  days post injection (40X-LS) note relatively intact 
multinucleated fibers. 
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Figure 13. 15 days post injection (lOOXLS) Point A reveals nuclear 
fragmentation leaving behind normal appearing nuclear 
fibers with peripherally placed sacrolemma nucl ei. 
51 
Figure 14. Day 7 Saline central (40XLS) reveals a localized region of 
degeneration following the same pattern as the lesion 
produced by l ocal anesthetics. 
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